Evaluation of gene expression in a single antibiotic exposure-derived isolate of Salmonella enterica Typhimurium 14028 possessing resistance to multiple antibiotics

Foodborne Pathogens and Disease

Volumn 5, Issue 2, 2008, Pages 205-221

  Dowd, Scot E ^a   Killinger Mann, Karen ^b   Brashears, Mindy ^c   Fralick, Joe ^d  

^a AGRICULTURAL RESEARCH SERVICE   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

^c TEXAS TECH UNIVERSITY   (United States)

^d TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFOXITIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; KANAMYCIN; LIPOPOLYSACCHARIDE; NALIDIXIC ACID; PEPTIDOGLYCAN; PHOP PROTEIN; STREPTOMYCIN; SULFAFURAZOLE; TETRACYCLINE; TRANSCRIPTOME;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; FLAGELLUM; GENE EXPRESSION; GENE REPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; MICROARRAY ANALYSIS; NONHUMAN; PATHOGENICITY ISLAND; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALMONELLA ENTERICA; SYNTHESIS;

ADAPTATION, PHYSIOLOGICAL; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE EXPRESSION REGULATION, BACTERIAL; GENES, BACTERIAL; MICROBIAL SENSITIVITY TESTS; NALIDIXIC ACID; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SALMONELLA TYPHIMURIUM;

SALMONELLA; SALMONELLA ENTERICA;

EID: 42149163437     PISSN: 15353141     EISSN: None     Source Type: Journal    
DOI: 10.1089/fpd.2007.0062     Document Type: Article

References (100)

1. Alekshun MN and Levy SB. The mar regulon: multiple resistance to antibiotics and other toxic chemicals. Trends Microbiol. 1999;7:410-413.
2. Aono R. Improvement of organic solvent tolerance level of Escherichia coli by overexpression of stress-responsive genes. Extremophiles 1998;2:239-248.
3. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 2000;25:25-29.
4. Bader MW, Navarre WW, Shiau W, et al. Regulation of Salmonella typhimurium virulence gene expression by cationic antimicrobial peptides. Mol. Microbiol. 2003;50:219-230.
5. Baucheron S, Chaslus-Dancla E, and Cloeckaert A. Role of TolC and parC mutation in high-level fluoroquinolone resistance in Salmonella enterica serotype Typhimurium DT204. J. Antimicrob. Chemother. 2004;53:657-659.
6. Benjamini Y and Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J.R. Statist. Soc. B 1995;57:289-300.
7. Blanc-Potard AB and Lafay B. MgtC as a horizontally-acquired virulence factor of intracellular bacterial pathogens: evidence from molecular phylogeny and comparative genomics. J. Mol. Evol. 2003;57:479-486.
8. Braoudaki M and Hilton AC. Mechanisms of resistance in Salmonella enterica adapted to erythromycin, benzalkonium chloride and triclosan. Int. J. Antimicrob. Agents 2005;25:31-37.
9. Brown MH, Paulsen IT, and Skurray RA. The multidrug efflux protein NorM is a prototype of a new family of transporters. Mol. Microbiol. 1999;31:394-395.
10. Bush K, Jacoby GA, and Medeiros AA. A functional classification scheme for beta-lactamases and its correlation withmolecular structure.Antimicrob. Agents Chemother. 1995;39:1211-1233.
11. Cao Z and Klebba PE. Mechanisms of colicin binding and transport through outer membrane porins. Biochimie 2002;84:399-412.
12. Chakravortty D, Rohde M, Jager L, et al. Formation of a novel surface structure encoded by Salmonella pathogenicity island 2. EMBO J. 2005;24:2043-2052.
13. Charbonnier Y, Gettler B, Francois P, et al. A generic approach for the design of whole-genome oligoarrays, validated for genomotyping, deletion mapping and gene expression analysis on Staphylococcus aureus. BMC Genomics 2005;6:95.
14. Cohen SP, McMurry LM, Hooper DC, et al. Crossresistance to fluoroquinolones in multiple-antibioticresistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob. Agents Chemother. 1989;33:1318-1325.
15. Cohen SP, McMurry LM, and Levy SB. marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli. J. Bacteriol. 1988;170:5416-5422.
16. Cohen SP, Yan W, and Levy SB. A multidrug resistance regulatory chromosomal locus is widespread among enteric bacteria. J. Infect. Dis. 1993;168:484-488.
17. Deiwick J, Nikolaus T, Shea JE, et al. Mutations in Salmonella pathogenicity island 2 (SPI2) genes affecting transcription of SPI1 genes and resistance to antimicrobial agents. J. Bacteriol. 1998;180:4775-4780.
18. Dennis Jr G, Sherman BT, Hosack DA, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4:3.
19. Detweiler CS, Monack DM, Brodsky IE, et al. virK, somA and rcsC are important for systemic Salmonella enterica serovar Typhimurium infection and cationic peptide resistance. Mol. Microbiol. 2003;48:385- 400.
20. Dowd SE. HTGOFAT: High Throughput Functional Annotation Toolkit. Available at http://liru.ars.usda.gov/mainbioinformatics.html. Accessed 30 December 2005.
21. Dowd SE, Killinger-Mann K, Blanton J, et al. Positive adaptive state: microarray evaluation of gene expression in Salmonella enterica Typhimurium upon exposure to sub-therapeutic levels of nalidixic acid. Foodborne Pathog. Dis. 2007;4:40-50.
22. Evans K, Passador L, Srikumar R, et al. Influence of the MexAB-OprM multidrug efflux system on quorum sensing in Pseudomonas aeruginosa. J. Bacteriol. 1998;180:5443-5447.
23. Felix A and Callow BR. Paratyphoid-B Vi-phage typing. Lancet 1951;2:10-14.
24. Fralick JA. Evidence that TolC is required for functioning of the Mar/AcrAB efflux pump of Escherichia coli. J. Bacteriol. 1996;178:5803-5805.
25. 2+ as an extracellular signal: environmental regulation of Salmonella virulence. Cell 1996;84:165-174.
26. Gardete S, Ludovice AM, Sobral RG, et al. Role of murE in the expression of beta-lactam antibiotic resistance in Staphylococcus aureus. J. Bacteriol. 2004;186:1705-1713.
27. Gayet S, Chollet R, Molle G, et al. Modification of outer membrane protein profile and evidence suggesting an active drug pump in Enterobacter aerogenes clinical strains. Antimicrob. Agents Chemother. 2003;47:1555-1559.
28. Gensberg K, Jin YF, and Piddock LJ. A novel gyrB mutation in a fluoroquinolone-resistant clinical isolate of Salmonella typhimurium. FEMS Microbiol. Lett. 1995;132:57-60.
29. Giraud E, Cloeckaert A, Kerboeuf D, et al. 2000. Evidence for active efflux as the primary mechanism of resistance to ciprofloxacin in Salmonella enterica serovar typhimurium. Antimicrob. Agents Chemother. 44:1223-1228.
30. Gomez MJ and Neyfakh AA. Genes involved in intrinsic antibiotic resistance of Acinetobacter baylyi. Antimicrob. Agents Chemother. 2006;50:3562-3567.
31. Guina T, Yi EC, Wang H, et al. A PhoP-regulated outer membrane protease of Salmonella enterica serovar typhimurium promotes resistance to alpha-helical antimicrobial peptides. J. Bacteriol. 2000;182:4077- 4086.
32. Hancock RE. The bacterial outer membrane as a drug barrier. Trends Microbiol. 1997;5:37-42.
33. Hancock RE and Reeves P. Lipopolysaccharide-deficient, bacteriophage-resistant mutants of Escherichia coli K-12. J. Bacteriol. 1976;127:98-108.
34. Harley KT and Saier Jr MH. A novel ubiquitous family of putative efflux transporters. J. Mol. Microbiol. Biotechnol. 2000;2:195-198.
35. Hawkey PM. Mechanisms of quinolone action and microbial response. J. Antimicrob. Chemother. 2003;51 (Suppl 1):29-35.
36. Hensel M, Shea JE, Baumler AJ, et al. Analysis of the boundaries of Salmonella pathogenicity island 2 and the corresponding chromosomal region of Escherichia coli K-12. J. Bacteriol. 1997;179:1105-1111.
37. Hensel M, Shea JE, Waterman SR, et al. Genes encoding putative effector proteins of the type III secretion system of Salmonella pathogenicity island 2 are required for bacterial virulence and proliferation in macrophages. Mol. Microbiol. 1998;30:163-174.
38. Hooper DC. Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin. Infect. Dis. 2001;32 Suppl 1:S9-S15.
39. Jacoby GA. Mechanisms of resistance to quinolones. Clin. Infect. Dis. 2005;41(Suppl 2):S120-S126.
40. Kieboom J, Dennis JJ, Zylstra GJ, et al. Active efflux of organic solvents by Pseudomonas putida S12 is induced by solvents. J. Bacteriol. 1998;180:6769-6772.
41. Killinger Mann K. The Repercussions of Exposure to Nalidixic Acid for Salmonella Typhimurium: Alterations in Phenotype, Multi-Drug Resistance and Lactic Acid Susceptibility. Lubbock, TX: Texas Tech University, 2005.
42. Kukkonen M and Korhonen TK. The omptin family of enterobacterial surface proteases/adhesins: from housekeeping in Escherichia coli to systemic spread of Yersinia pestis. Int. J. Med. Microbiol. 2004;294:7-14.
43. Levy DD, Sharma B, and Cebula TA. Single-nucleotide polymorphism mutation spectra and resistance to quinolones in Salmonella enterica serovar Enteritidis with a mutator phenotype. Antimicrob. Agents Chemother. 2004;48:2355-2363.
44. Li XZ, Zhang L, and Poole K. Role of the multidrug efflux systems of Pseudomonas aeruginosa in organic solvent tolerance. J. Bacteriol. 1998;180:2987-2991.
45. Liu J, Rutz JM, Feix JB, et al. Permeability properties of a large gatedchannelwithintheferricenterobactin receptor, FepA. Proc.Natl. Acad. Sci. U. S. A. 1993;90:10653-10657.
46. Ludovice AM, Wu SW, and De LH. Molecular cloning and DNA sequencing of the Staphylococcus aureus UDP-N-acetylmuramyl tripeptide synthetase (murE) gene, essential for the optimal expression of methicillin resistance. Microb. Drug Resist. 1998;4:85-90.
47. Ma D, Alberti M, Lynch C, et al. The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals. Mol. Microbiol. 1996;19:101-112.
48. Ma D, Cook DN, Alberti M, et al. Molecular cloning and characterization of acrA and acrE genes of Escherichia coli. J. Bacteriol. 1993;175:6299-6313.
49. Ma D, Cook DN, Hearst JE, et al. Efflux pumps and drug resistance in gram-negative bacteria. Trends Microbiol. 1994;2:489-493.
50. Maira-Litran T, Allison DG, Gilbert P. Expression of the multiple antibiotic resistance operon (mar) during growth of Escherichia coli as a biofilm. J. Appl. Microbiol. 2000;88:243-247.
51. McClelland M, Sanderson KE, Spieth J, et al. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 2001;413:852-856.
52. McMurry LM, Oethinger M, and Levy SB. Overexpression of marA, soxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol. Lett. 1998;166:305-309.
53. Miller SI, Kukral AM, and Mekalanos JJ. Atwo-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc. Natl. Acad. Sci. U. S. A. 1989;86:5054-5058.
54. Miller SI and Mekalanos JJ. Constitutive expression of the phoP regulon attenuates Salmonella virulence and survival within macrophages. J. Bacteriol. 1990;172:2485-2490.
55. Miyamae S, Nikaido H, Tanaka Y, et al. Active efflux of norfloxacin by Bacteroides fragilis. Antimicrob. Agents Chemother. 1998;42:2119-2121.
56. Moken MC, McMurry LM, and Levy SB. Selection of multiple-antibiotic- resistant (mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and acrAB loci. Antimicrob. Agents Chemother. 1997;41:2770-2772.
57. Moncrief MB and Maguire ME. Magnesium and the role of MgtC in growth of Salmonella typhimurium. Infect. Immun. 1998;66:3802-3809.
58. Monsieurs P, De KS, Navarre WW, et al. Comparison of the PhoPQ regulon in Escherichia coli and Salmonella typhimurium. J. Mol. Evol. 2005;60:462-474.
59. Morita Y, Kodama K, Shiota S, et al. NorM, a putative multidrug efflux protein, of Vibrio parahaemolyticus and its homolog in Escherichia coli. Antimicrob. Agents Chemother. 1998;42:1778-1782.
60. Moskovitz J. Roles of methionine suldfoxide reductases in antioxidant defense, protein regulation and survival. Curr. Pharm. Des. 2005;11:1451- 1457.
61. Murray GL, Attridge SR, and Morona R. Inducible serum resistance in Salmonella typhimurium is dependent on wzz(fepE)-regulated very long O antigen chains. Microbes Infect. 2005;7:1296-1304.
62. Navarre WW, Halsey TA, Walthers D, et al. Co-regulation of Salmonella enterica genes required for virulence and resistance to antimicrobial peptides by SlyA and PhoP/PhoQ. Mol. Microbiol. 2005;56:492-508.
63. Nikaido H. Antibiotic resistance caused by gram-negative multidrug efflux pumps. Clin. Infect. Dis. 1998;27(Suppl 1):S32-S41.
64. Ochman H, Soncini FC, Solomon F, et al. Identification of a pathogenicity island required for Salmonella survival in host cells. Proc. Natl. Acad. Sci. U. S. A. 1996;93:7800-7804.
65. Ogata H, Goto S, Sato K, et al. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 1999;27:29-34.
66. Okusu H, Ma D, and Nikaido H. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic- resistance (Mar) mutants. J. Bacteriol. 1996;178:306-308.
67. Olliver A, Valle M, Chaslus-Dancla E, et al. Overexpression of the multidrug efflux operon acrEF by insertional activation with IS1 or IS10 elements in Salmonella enterica serovar Typhimurium DT204 acrB mutants selected with fluoroquinolones. Antimicrob. Agents Chemother. 2005;49:289-301.
68. Pangon B, Bizet C, Bure A, et al. In vivo selection of a cephamycin-resistant, porin-deficient mutant of Klebsiella pneumoniae producing a TEM-3 beta-lactamase. J. Infect. Dis. 1989;159:1005-1006.
69. Paulsen IT, Brown MH, and Skurray RA. Proton-dependent multidrug efflux systems. Microbiol. Rev. 1996;60:575-608.
70. Pearson JP, Van DC, and Iglewski BH. Active efflux and diffusion are involved in transport of Pseudomonas aeruginosa cell-to-cell signals. J. Bacteriol. 1999;181:1203-1210.
71. Pechous R, Ledala N, Wilkinson BJ, et al. Regulation of the expression of cell wall stress stimulon member gene msrA1 in methicillin-susceptible or -resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 2004;48:3057-3063.
72. Piddock LJ. Mechanisms of fluoroquinolone resistance: an update 1994-1998. Drugs 1999;58(Suppl 2):11-18.
73. Piddock LJ. Multidrug-resistance efflux pumps-not just for resistance. Nat. Rev. Microbiol. 2006;4:629-636.
74. Prescott JF, Baggot JD, and Walker RD. Antimicrobial Therapy in Veterinary Epidemiology. 3rd edition. Ames: Iowa State University Press, 2000.
75. Rapin AM, Kalckar HM, and Alberico L. The metabolic basis for masking of receptor-sites on E. coli K-12 for C21, a lipopolysaccharide core-specific phage. Arch. Biochem. Biophys. 1968;128:95-105.
76. Reyna F, Huesca M, Gonzalez V, et al. Salmonella typhimurium gyrA mutations associated with fluoroquinolone resistance. Antimicrob. Agents Chemother. 1995;39:1621-1623.
77. Rida S, Caillet J, and Alix JH. Amplification of a novel gene, sanA, abolishes a vancomycin-sensitive defect in Escherichia coli. J. Bacteriol. 1996;178:94-102.
78. Rubens CE, McNeill WF, and Farrar Jr WE. Evolution of multiple-antibiotic-resistance plasmids mediated by transposable plasmid deoxyribonucleic acid sequences. J. Bacteriol. 1979;140:713-719.
79. Sanders CC. Beta-lactamases of gram-negative bacteria: new challenges for new drugs. Clin. Infect. Dis. 1992;14:1089-1099.
80. Sanders CC and Sanders Jr WE. Beta-lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin. Infect. Dis. 1992;15:824-839.
81. Santiviago CA, Toro CS, Hidalgo AA, et al. Global regulation of the Salmonella enterica serovar Typhimurium major porin, OmpD. J. Bacteriol. 2003;185:5901-5905.
82. Sayah RS, Kaneene JB, Johnson Y, et al. Patterns of antimicrobial resistance observed in Escherichia coli isolates obtained from domestic- and wild-animal fecal samples, human septage, and surface water. Appl. Environ. Microbiol. 2005;71:1394-1404.
83. Schwarz S, Kehrenberg C, Doublet B, et al. Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol. Rev. 2004;28:519-542.
84. Schweizer HP. Intrinsic resistance to inhibitors of fatty acid biosynthesis in Pseudomonas aeruginosa is due to efflux: application of a novel technique for generation of unmarked chromosomal mutations for the study of efflux systems. Antimicrob. Agents Chemother. 1998;42:394-398.
85. Shafer WM, Qu X, Waring AJ, et al. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. U. S. A. 1998;95:1829-1833.
86. Shea JE, Hensel M, Gleeson C, et al. Identification of a virulence locus encoding a second type III secretion system in Salmonella typhimurium. Proc. Natl. Acad. Sci. U. S. A. 1996;93:2593-2597.
87. Shi Y, Latifi T, Cromie MJ, et al. Transcriptional control of the antimicrobial peptide resistance ugtL gene by the Salmonella PhoP and SlyA regulatory proteins. J. Biol. Chem. 2004;279:38618-38625.
88. Soncini FC, Garcia VE, Solomon F, et al. Molecular basis of the magnesium deprivation response in Salmonella typhimurium: identification of PhoP-regulated genes. J. Bacteriol. 1996;178:5092-5099.
89. Spratt BG. Resistance to antibiotics mediated by target alterations. Science 1994;264:388-393.
90. Srikumar R, Kon T, Gotoh N, et al. Expression of Pseudomonas aeruginosa multidrug efflux pumps MexA-MexBOprM and MexC-MexD-OprJ in a multidrug-sensitive Escherichia coli strain. Antimicrob. Agents Chemother. 1998;42:65-71.
91. Stoorvogel J, van Bussel MJ, and van de Klundert JA. Biological characterization of an Enterobacter cloacae outer membrane protein (OmpX). J. Bacteriol. 1991;173:161-167.
92. Takiff HE, Cimino M, Musso MC, et al. Efflux pump of the proton antiporter family confers low-level fluoroquinolone resistance in Mycobacterium smegmatis. Proc. Natl. Acad. Sci. U. S. A. 1996;93:362-366.
93. Tatusov RL, Fedorova ND, Jackson JD, et al. The COG database: an updated version includes eukaryotes. BMC Bioinformatics 2003;4:41.
94. Tenover FC, McDougal LK, Goering RV, et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J. Clin. Microbiol. 2006;44:108-118.
95. Thanassi DG, Cheng LW, and Nikaido H. Active efflux of bile salts by Escherichia coli. J. Bacteriol. 1997;179:2512-2518.
96. van den Bogaard AE, London N, Driessen C, et al. Antibiotic resistance of faecal Escherichia coli in poultry, poultry farmers and poultry slaughterers. J. Antimicrob. Chemother. 2001;47:763-771.
97. Wing HJ, Goldman SR, Ally S, et al. Modulation of an outer membrane protease contributes to the virulence defect of Shigella flexneri strains carrying a mutation in the virK locus. Infect. Immun. 2005;73:1217-1220.
98. Wolfe AJ and Berg HC. Migration of bacteria in semisolid agar. Proc. Natl. Acad. Sci. U. S. A. 1989;86:6973-6977.
99. Wu CH, Huang H, Arminski L, et al. The Protein Information Resource: an integrated public resource of functional annotation of proteins. Nucleic Acids Res. 2002;30:35-37.
100. Zinder ND and Lederberg J. Genetic exchange in Salmonella. J. Bacteriol. 1952;64:679-699.